fluoxetine and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

fluoxetine has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gaebel, W; Janz, A; Klimke, A; Larisch, R; Müller-Gärtner, HW; Vosberg, H	1

Other Studies

1 other study(ies) available for fluoxetine and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

Article	Year
Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT. Psychiatry research, 1999, Apr-26, Volume: 90, Issue:2 Topics: Adult; Aged; Anti-Anxiety Agents; Benzamides; Benzodiazepines; Case-Control Studies; Contrast Media; Corpus Striatum; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Paroxetine; Pyrrolidines; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed, Single-Photon	1999

Article

Year

Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.

Psychiatry research, 1999, Apr-26, Volume: 90, Issue:2

Topics: Adult; Aged; Anti-Anxiety Agents; Benzamides; Benzodiazepines; Case-Control Studies; Contrast Media; Corpus Striatum; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Paroxetine; Pyrrolidines; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed, Single-Photon

1999